R848 clinical trials

Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)

This study looks at how people's lungs respond to a harmless mist that acts like a virus. It aims to understand lung inflammation better, especially in people with asthma, to help develop new treatments for respiratory infections without causing actual illness.